The Ah Locus: Genetic Differences in Toxicity, Cancer, Mutation, and Birth Defects

References

• Williams R. T. Detoxification mechanisms. The Metabolism and Detoxification of Drugs, Toxic Substances, and Other Organic Compounds, 2nd ed. John Wiley & Sons, New York 1959
   Google Scholar
• Motulsky A. G. Pharmacogenetics. Progr. Med. Genet. 1964; 3: 49
   Google Scholar
• Nebert D. W. The 1986 Bernard B. Brodie Award Lecture: the genetic regulation of drug-metabolizing enzymes. Drug Metab. Disp. 1988; 16: 1
   PubMedGoogle Scholar
• Nebert D. W., Gelboin H. V. Thein vivoin vitro induction of aryl hydrocarbon hydroxylase in mammalian cells of different species, tissues, strains, and developmental and hormonal states. Arch. Biochem. Biophys 1969; 134: 76
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Gonzalez F. J. P450 genes: structure, evolution and regulation. Annu. Rev. Biochem. 1987; 56: 945
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J. The molecular biology of cytochrome P450s. Pharmacol. Rev. 1988; 40: 243
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Goujon F. M., Gielen J. E. Genetic regulation of monoxygenase activity. Belgium 1971; 240, inFonds de la Recherche Scientifique Medicale, Groupes de Contact, 11, ru d'Egmont, Bruxelles 5
   Google Scholar
• Kellermann G., Luyten-Kellermann M., Shaw C. R. Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am. J. Hum. Genet. 1973; 25: 327
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Gelboin H. V. Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. I. Assay and properties of induced enzyme. J. Biol. Chem. 1968; 243: 6242
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Gelboin H. V. Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. II. Cellular responses during enzyme induction. J. Biol. Chem. 1968; 243: 6250
   PubMed Web of Science ®Google Scholar
• Whitlock J. P., Jr. The regulation of gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Pharmacol. Rev. 1987; 39: 147
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Jones J. E. Regulation of the mammalian cytochrome P.450 (CYPIA1) gene. Int. J. Biochem. 1989; 21: 243
   PubMedGoogle Scholar
• Nebert D. W., Nelson D. R., Adesnik M., Coon M. J., Esta-Brook R. W., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Kemper B., Levin W., Phillips I. R., Sato R., Waterman M. R. The P450 superfamily: update on listing of all genes and recommended nomenclature of the chromosomal loci. DNA 1989; 8: 1
   PubMedGoogle Scholar
• Miller W. L. Molecular biology of steroid hormone synthesis. Endocrine Rev. 1988; 9: 295
   PubMed Web of Science ®Google Scholar
• Gielen J. E., Goujon F. M., Nebert D. W. Genetic regulation of aryl hydrocarbon hydroxylase induction. II. Simple Mendelian expression in mouse tissues in vivo. J. Biol. Chem. 1972; 247: 1125
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Negishi M., Lang M. A., Hjelmeland L. M., Eisen H. J. TheAh locus, a multigene family necessary for survival in a chemically adverse environment: comparison with the immune system. Adv. Genet. 1982; 21: 1
   PubMed Web of Science ®Google Scholar
• Taylor B. A. Strain distribution and linkage tests of 7,12-dimethyl-benzanthracene (DMBA) inflammatory response in mice. Life Sci. 1971; 10: 1127
   Google Scholar
• Kodama Y., Bock F. G. Benzo[α]pyrene-metabolizing enzyme activity of livers of various strains of mice. Cancer Res. 1970; 30: 1846
   PubMedGoogle Scholar
• Thomas P. E., Kouri R. E., Button J. J. The genetics of aryl hydrocarbon hydroxylase induction in mice: a single gene difference between C57BL/6J and DBA/2J. Biochem. Genet. 1972; 6: 157
   PubMed Web of Science ®Google Scholar
• Robinson J. R., Nebert D. W. Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism. Mol. Pharmacol. 1974; 10: 484
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Felton J. S. Importance of genetic factors influencing the metabolism of foreign compounds. Fed. Proc. 1976; 35: 1133
   PubMedGoogle Scholar
• Nebert D. W., Jensen N. M. TheAh locus: genetic regulation of the metabolism of carcinogens, drugs and other environmental chemicals by cytochrome P450-mediated monooxygenases. Crit. Rev. Biochem. 1979; 6: 401
   PubMed Web of Science ®Google Scholar
• Lu A. Y. H., Coon M. J. Resolution of the cytochrome P-450-containing ω-hydroxylation system of liver microsomes into three components. J. Biol., Chem. 1968; 243: 1331
   PubMed Web of Science ®Google Scholar
• Haugen D. A., Coon M. J., Nebert D. W. Induction of multiple forms of mouse liver cytochrome P-450. Evidence for genetically controlledde novo protein synthesis in response to treatment with T-naphthoflavone or phenobarbital. J. Biol. Chem. 1976; 251: 1817
   PubMedGoogle Scholar
• Atlas S. A., Thorgeirsson S. S., Boobis A. R., Kumaki K., Nebert D. W. Differential induction of murineAh locus-associated monooxygenase activities in rabbit liver and kidney. Biochem. Pharmacol. 1975; 24: 2111
   PubMed Web of Science ®Google Scholar
• Atlas S. A., Boobis A. R., Felton J. S., Thorgeirsson S. S., Nebert D. W. Ontogenetic expression of polycyclic aromatic compound-inducible monooxygenase activities and forms of cytochrome P-450 in the rabbit. J. Biol. Chem. 1977; 252: 4712
   PubMed Web of Science ®Google Scholar
• Guenthner T. M., Nebert D. W. Evidence in rat and mouse liver for temporal control of two forms of cytochrome P-450 inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Eur. J. Biochem. 1978; 91: 449
   PubMedGoogle Scholar
• Negishi M., Nebert D. W. Structural gene products of theAh locus. Genetic and immunochemical evidence for two forms of mouse liver cytochrome P-450 induced by 3-methylcholanthrene. J. Biol. Chem. 1979; 254: 11015
   PubMed Web of Science ®Google Scholar
• Negishi M., Jensen N. M., Garcia F. S., Nebert D. W. Structural gene products of the murineAh locus. Differences in ontogenesis, membrane location, and glucosamine incorporation between liver microsomal cytochromes P1-450 and P-448 induced by polycyclic aromatic compounds. Eur. J. Biochem. 1981; 115: 585
   PubMedGoogle Scholar
• Johnson E. F., Muller-Eberhard U. Resolution of two forms of cytochrome P-450 from liver microsomes of rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 1977; 252: 2839
   PubMed Web of Science ®Google Scholar
• Reik L. M., Levin W., Ryan D. E., Thomas P. E. Immunochemical relatedness of rat hepatic microsomal cytochromes P-450c and P-450d. J. Biol. Chem. 1982; 257: 3950
   PubMed Web of Science ®Google Scholar
• Negishi M., Nebert D. W. Structural gene products of theAh complex. Increases in large mRNA from mouse liver associated with cytochrome Pi-450 induction by 3-methylcholanthrene. J. Biol. Chem. 1981; 256: 3085
   PubMed Web of Science ®Google Scholar
• Raucy J. L., Johnson E. F. Variations among untreated rabbits in benzo(a)pyrene metabolism and its modulation by 7,8-benzoflavone. Mol. Pharmacol. 1985; 27: 296
   PubMedGoogle Scholar
• Meehan R. R., Speed R. M., Gosden J. R., Rout D., Hutton J. J., Taylor B. A., Hilkens J., Kroezen V., Hilgers J., Adesnik M., Friedberg T., Hastic N. D., Wolf C. R. Chromosomal organization of the cytochromeP450-2C gene family in the mouse: a locus associated with constitutive aryl hydrocarbon hydroxylase. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 2662
   PubMedGoogle Scholar
• Thorgeirsson S. S., Nebert D. W. TheAh locus and the metabolism of chemical carcinogens and other foreign compounds. Adv. Cancer Res. 1977; 25: 149
   PubMedGoogle Scholar
• Jerina D. M. The 1982 Bernard B. Brodie Award Lecture: metabolism of aromatic hydrocarbons by the cytochrome P-450 system and epoxide hydrolase. Drug Metab. Disp. 1983; 11: 1
   PubMed Web of Science ®Google Scholar
• Conney A. B. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture. Cancer Res. 1982; 42: 4875
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Nebert D. W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 1982; 34: 189
   PubMed Web of Science ®Google Scholar
• Gonzalez F. J., Tukey R. H., Nebert D. W. Structural gene products of theAh locus. Transcriptional regulation of cytochrome P1-450 and P3-450 mRNA levels by 3-methylcholanthrene. Mol. Pharmacol. 1984; 26: 117
   PubMed Web of Science ®Google Scholar
• Kimura S., Gonzalez F. J., Nebert D. W. Tissue-specific expression of the mouse dioxin-inducible P1450 and P3450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues. Mol Cell. Biol. 1986; 6: 1471
   PubMed Web of Science ®Google Scholar
• Soderqvist P., Poellinger L., Toftgard R., Gustafsson J.-A. Differential expression of the cytochrome P-450c and P-450d genes in the rat ventral prostate and liver. Cancer Res. 1988; 48: 3045
   PubMedGoogle Scholar
• Pasco D. S., Boyum K. W., Merchant S. N., Chalberg S. C., Fagan J. B. Transcriptional and post-transcriptional regulation of the genes encoding cytochromes P450c and P450din vivo and in primary hepatocyte cultures. J. Biol. Chem. 1988; 263: 8671
   PubMed Web of Science ®Google Scholar
• Silver G., Krauter K. S. Expression of cytochromes P-450c and P-450d mRNAs in cultured rat hepatocytes. 3-Methylcholanthrene induction is regulated primarily at the post-transcriptional level. J. Biol. Chem. 1988; 263: 11802
   PubMed Web of Science ®Google Scholar
• Dey A., Westphal H., Nebert D. W. Cell-specific induction of mouseCYPIA1 mRNA during development. Proc. Natl. Acad. Sci. U.S.A., in press
   Google Scholar
• Dey A., Westphal H., Jones J. E., Nebert D. W. CellspecificCypla1Cypla2 induction by 3-methylcholanthrene in mouse tissues, submitted
   Google Scholar
• Poland A., Glover E. Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin, a potent inducer of aryl hydrocarbon hydroxylase, with 3-methylcholanthrene. Mol. Pharmacol 1974; 10: 349
   PubMed Web of Science ®Google Scholar
• Poland A. P., Glover E., Robinson J. R., Nebert D. W. Genetic expression of aryl hydrocarbon hydroxylase activity. Induction of monooxygenase activities and cytochrome P1450 formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice genetically “nonresponsive” to other aromatic hydrocarbons. J. Biol. Chem. 1974; 249: 5599
   PubMed Web of Science ®Google Scholar
• Poland A. P., Glover E., Kende A. S. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. J. Biol Chem. 1976; 251: 4936
   PubMed Web of Science ®Google Scholar
• Bradfield C. A., Poland A. P. A competitive binding assay for 2,3,7,8-tetrachlorodibenzo-p-dioxin and related ligands of the Ah receptor. Mol. Pharmacol 1988; 34: 682
   PubMed Web of Science ®Google Scholar
• Carlstedt-Duke J., Elfstrom G., Snochowski M., Hogberg B., Gustafsson J.-A. Detection of the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) receptor in rat liver by isoelectric focusing in polyacrylamide gels. Toxicol Lett. 1978; 2: 365
   Google Scholar
• Okey A. B., Bondy G. P., Mason M. E., Kahl G. F., Eisen H. J., Guenthner T. M., Nebert D. W. Regulatory gene product of theAh locus. Characterization of the cytosolic inducer-receptor complex and evidence for its nuclear translocation. J. Biol. Chem. 1979; 254: 11636
   PubMed Web of Science ®Google Scholar
• Hannah R. R., Nebert D. W., Eisen H. J. Regulatory gene product of theAh complex. Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3-methylcholanthrene binding to several moieties in mouse liver cytosol. J. Biol. Chem. 1981; 256: 4584
   PubMedGoogle Scholar
• Tukey R. H., Hannah R. R., Negishi M., Nebert D. W., Eisen H. J. TheAh locus. Correlation of intranuclear appearance of inducer-receptor complex with induction of cytochrome P,450 mRNA. Cell 1982; 31: 275
   PubMed Web of Science ®Google Scholar
• Gasiewicz T. A., Neal R. A. The examination and quantitation of tissue cytosolic receptors for 2,3,7,8-tetrachlorodibenzo-p-dioxin using hydroxylapatite. Anal. Biochem. 1982; 124: 1
   PubMed Web of Science ®Google Scholar
• Gillner M. Polyacrylamide concentration gradient gel electrophoresis of the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) receptor in rat liver cytosol. Toxicol. Lett. 1988; 42: 273
   PubMedGoogle Scholar
• Okey A. B., Bondy G. P., Mason M. E., Nebert D. W., Forster-Gibson C., Muncan J., Dufresne M. J. Temperature-dependent cytosol-to-nucleus translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in continuous cell culture lines. J. Biol. Chem. 1980; 255: 11415
   PubMed Web of Science ®Google Scholar
• Hannah R. R., Lund J., Poellinger L., Gillner M., Gustafsson J.-A. Characterization of the DNA-binding properties of the receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Eur. J. Biochem. 1986; 156: 237
   PubMedGoogle Scholar
• Gasiewicz T. A., Bauman P. A. Heterogeneity of the rat hepatic Ah receptor and evidence for transformationin vitroin vivo. J. Biol. Chem. 1987; 262: 2116
   PubMed Web of Science ®Google Scholar
• Prokipcak R. D., Okey A. B. Physicochemical characterization of the nuclear form of Ah receptor from mouse hepatoma cells exposed in culture to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch. Biochem. Biophys 1988; 267: 811
   PubMedGoogle Scholar
• Hapgood J., Cuthill S., Denis M., Poellinger L., Gustafsson J.-A. Specific protein-DNA interactions at a xenobiotic-responsive element: copurification of dioxin receptor and DNA-binding activity. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 60
   PubMedGoogle Scholar
• Denison M. S., Fisher J. M., Whitlock J. P., Jr. The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis. J. Biol. Chem. 1988; 263: 17221
   PubMed Web of Science ®Google Scholar
• Neuhold L. A., Shirayoshi Y., Ozato K., Jones J. E., Nebert D. W. Regulation of mouseCYPIA1 gene expression by dioxin. Requirement of twocis-acting elements during the induction process. Mol. Cell. Biol. 1989; 9: 2378
   PubMed Web of Science ®Google Scholar
• Nebert D. W. Multiple forms of inducible drug-metabolizing enzymes. A reasonable mechanism by which any organism can cope with adversity. Mol. Cell. Biochem. 1979; 27: 27
   PubMed Web of Science ®Google Scholar
• Poland A. P., Knutsen J. C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 1982; 22: 517
   PubMed Web of Science ®Google Scholar
• Halogenated Biphenyls. Terphenyls. Naphthalenes, Dibenzodioxins and Related Products, R. D. Kimbrough. Elsevier, Amsterdam 1989
   Google Scholar
• Cobb R. R., Stoming T. A., Whitney J. B., III. The aryl hydrocarbon hydroxylaseAh locus and a novel restriction-fragment length polymorphism (RFLP) are located on mouse chromosome 12. Biochem. Genet. 1987; 25: 401
   PubMedGoogle Scholar
• Poland A., Glover E., Taylor B. A. The murineAh locus: a new allele and mapping to chromosome 12. Mol. Pharmacol. 1988; 32: 471
   Google Scholar
• Hankinson O. Dominant and recessive aryl hydrocarbon hydroxylase-deficient mutants of mouse hepatoma line, Hepa-1, and assignment of recessive mutants to three complementation groups. Somatic Cell Genet. 1983; 9: 497
   PubMedGoogle Scholar
• Karenlampi S. O., Legraverend C., Gudas J. M., Carramanzana N., Hankinson O. A third genetic locus affecting theAh (dioxin) receptor. J. Biol. Chem. 1988; 263: 10111
   PubMedGoogle Scholar
• Hildebrand C. E., Gonzalez F. J., Kozak C. A., Nebert D. W. Regional linkage analysis of the dioxin-inducible P-450 gene family on mouse chromosome 9. Biohcem. Biophys. Res. Commun. 1985; 130: 396
   PubMedGoogle Scholar
• Kouri R. E., Nebert D. W. Genetic regulation of susceptibility to polycyclic hydrocarbon-induced tumors in the mouse. Origins of Human Cancer, H. H. Hiatt, J. D. Watson, J. A. Winsten. CSHL Press, New York 1977; Vol. 4: 811
   Google Scholar
• Nebert D. W., Benedict W. F., Kouri R. E. Aromatic hydrocarbon-produced tumorigenesis and the genetic differences in aryl hydrocarbon hydroxylase induction. Chemical Carcinogenesis, P. O.P. Ts'o, J. A. DiPaolo. Marcel Dekker, New York 1974; 271
   Google Scholar
• Kouri R. E., Rude T. H., Joglekar R., Dansette P. M., Jerina D. M., Atlas S. A., Owens I. S., Nebert D. W. 2,3,7,8-Tetrachlorodibenzo-p-dioxin: cocarcinogen which enhances 3-meth-ylcholanthrene-initiated subcutaneous tumors in mice genetically “non-responsive” atAh locus. Cancer Res. 1978; 38: 2777
   PubMed Web of Science ®Google Scholar
• Poland A., Palen D., Glover E. Tumour promotion by TCDD in skin HRS/J hairless mice. Nature 1982; 300: 271
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Atlas S. A., Guenthner T. M., Kouri R. E. The Ah locus: genetic regulation of the enzymes which metabolize polycyclic hydrocarbons and the risk for cancer. Polycyclic Hydrocarbons and Cancer: Chemistry, Molecular Biology and Environment, P. O.P. Ts'o, H. V. Gelboin. Academic Press, New York 1978; Vol. 2: 345
   Google Scholar
• Abbott P. J. Strain-specific tumorigenesis in mouse skin induced by the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, and its relation to DNA adduct formation and persistence. Cancer Res. 1983; 43: 2261
   PubMed Web of Science ®Google Scholar
• Lubet R. A., Connolly G. M., Nebert D. W., Kouri R. E. Dibenz[a, h]anthracene-induced subcutaneous tumors in mice. Strain sensitivity and the role of carcinogen metabolism. Carcinogenesis 1983; 4: 513
   PubMedGoogle Scholar
• Kouri R. E., Connolly G. M., Nebert D. W., Lubet R. A. Association between susceptibility to dibenzanthracene-induced fibrosarcoma formation and theAh locus. Int. J. Cancer 1983; 32: 765
   PubMedGoogle Scholar
• Anderson L. M., Jones A. B., Riggs C. W., Ohshima M. Fetal mouse susceptibility to transplacental lung and liver carcinogenesis by 3-methylcholanthrene: positive correlation with responsivness to inducers of aromatic hydrocarbon metabolism. Carcinogenesis 1985; 6: 1389
   PubMed Web of Science ®Google Scholar
• Ames B. N., Lee F. D., Durston W. E. An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proc. Natl. Acad. Sci. U.S.A. 1973; 70: 782
   PubMed Web of Science ®Google Scholar
• Felton J. S., Nebert D. W. Mutagenesis of certain activated carcinogensin vitro associated with genetically mediated increases in monooxygenase activity and cytochrome P,-450. J. Biol. Chem. 1975; 250: 6769
   PubMed Web of Science ®Google Scholar
• Sims P., Grover P. L., Swaisland A., Pal K., Hewer A. Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide. Nature 1974; 252: 326
   PubMed Web of Science ®Google Scholar
• Selkirk J. K., Croy R. G., Gelboin H. V. Benzo[a]pyrene metabolites: efficient and rapid separation by high-pressure liquid chromatography. Science 1974; 184: 169
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Boobis A. R., Yagi H., Jerina D. M., Nebert D. W. The tentative identification of benzo[a]pyrene metabolite-nucleoside complexes producedin vitro by mouse liver microsomes. Mol. Pharmacol 1978; 14: 306
   PubMed Web of Science ®Google Scholar
• van Cantfort J., Gielen J. E., Nebert D. W. Benzo[a]pyrene metabolism in mouse liver. Association of both 7,8-epoxidation and covalent binding of a metabolite of the 7,8-diol with theAh locus. Biochem. Pharmacol. 1985; 34: 1821
   PubMedGoogle Scholar
• Weinstein I. B., Jeffrey A. M., Jennette K. W., Blobstein S. H., Harvey R. G., Harris C. C., Autrup H., Kasai H., Nakanishi K. Benzo[a]pyrene diol epoxides as intermediates in nucleic acid bindingin vitro. in vivo, Science 1976; 193: 592
   PubMed Web of Science ®Google Scholar
• Pelkonen O., Boobis A. R., Levitt R. C., Kouri R. E., Nebert D. W. Genetic differences in the metabolic activation of benzo[a]pyrene in mice. Attempts to correlate tumorigenesis with binding of reactive intermediates to DNA and with mutagenesis in vitro. Pharmacology 1979; 18: 281
   PubMed Web of Science ®Google Scholar
• Robinson J. R., Felton J. S., Levitt R. C., Thorgeirsson S. S., Nebert D. W. Relationship between “aromatic hydrocarbon responsiveness” and the survival times in mice treated with various drugs and environmental compounds. Mol. Pharmacol. 1975; 11: 850
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Levitt R. C., Jensen N. M., Lambert G. H., Felton J. S. Birth defects and aplastic anemia: differences in polycyclic hydrocarbon toxicity associated with theAh locus. Arch. Toxicol. 1977; 39: 109
   PubMed Web of Science ®Google Scholar
• Russell E. S., Bernstein S. E., McFarland E. C., Modeen W. R. The cellular basis of differential sensitivity of normal and genetically anemic mice. Radial. Res. 1963; 20: 677
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Jensen N. M., Levitt R. C., Felton J. S. Toxic chemical depression of the bone marrow and possible aplastic anemia explainable on a genetic basis. Clin. Toxicol 1980; 16: 99
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Jensen N. M. Benzo[a]pyrene-initiated leukemia in mice. Association with allelic differences at theAh locus. Biochem. Pharmacol. 1979; 27: 149
   Google Scholar
• Duran-Reynals M. L., Lilley F., Bosch A., Blank K. J. The genetic basis of susceptibility to leukemia induction in mice by 3-methylcholanthrene applied percutaneously. J. Exp. Med. 1978; 147: 459
   PubMed Web of Science ®Google Scholar
• Legraverend C., Harrison D. E., Ruscetti F. W., Nebert D. W. Bone marrow toxicity induced by oral benzo[a]pyrene: protection resides at the level of the intestine and liver. Toxicol. Appl. Pharmacol. 1983; 70: 390
   PubMed Web of Science ®Google Scholar
• Routledge P. A., Shand D. G. Presystemic drug elimination. Annu. Rev. Pharmacol. Toxicol. 1979; 19: 447
   PubMed Web of Science ®Google Scholar
• Prehn L. M., Lawler E. M. Rank order of sarcoma susceptibility among mouse strains reverses with low concentrations of carcinogen. Science 1979; 204: 309
   PubMed Web of Science ®Google Scholar
• Nebert D. W. Genetic differences in susceptibility to chemically induced myelotoxicity and leukemia. Environ. Health Perspect 1981; 39: 11
   PubMedGoogle Scholar
• Miller E. C., Miller J. A. Reactive metabolites as key intermediates in pharmacologic and toxicologic responses: examples from chemical Carcinogenesis. Biological Reactive Intermediates. II. Chemical Mechanisms and Biological Effects, R. Snyder, D. J. Jollow, D. V. Parke, G. G. Gibson, J. J. Kocsis, C. M. Witmer. Plenum Press, New York 1982; 1
   Google Scholar
• Kamataki T., Maeda K., Yamazoe Y., Matsuda N., Ishii K., Kato R. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes. Mol. Pharmacol. 1983; 24: 146
   PubMed Web of Science ®Google Scholar
• Morgan E. T., Koop D. R., Coon M. J. Comparison of six rabbit liver cytochrome P-450 isozymes in formation of a reactive metabolite of acetaminophen. Biochem. Biophys. Res. Commun. 1983; 112: 8
   PubMed Web of Science ®Google Scholar
• Dahlin D. C., Miwa G. T., Lu A. Y. H., Nelson S. D. N-acetyl-p-benzoquinone imine: a cytochrome P450-mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. U.S.A. 1984; 81: 1327
   PubMed Web of Science ®Google Scholar
• Potter D. W., Hinson J. A. Mechanisms of acetaminophen oxidation to N-acetyl-p-benzoquinone imine by horseradish peroxidase and cytochrome P450. J. Biol. Chem. 1987; 262: 966
   PubMed Web of Science ®Google Scholar
• Harvison P. J., Guengerich F. P., Rashed M. S., Nelson S. D. Cytochrome P450 isozyme selectivity in the oxidation of acetaminophen. Chem. Res. Toxicol. 1988; 1: 47
   PubMed Web of Science ®Google Scholar
• Thorgeirsson S. S., Felton J. S., Nebert D. W. Genetic differences in the aromatic hydrocarbon-inducible N-hydroxylation of 2-acetylaminofluorene and acetaminophen-produced hepatotoxicity in mice. Mol. Pharmacol. 1975; 11: 159
   PubMed Web of Science ®Google Scholar
• Raina V., Williams C. J., Gurtoo H. L. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and β-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins. Biochem. Pharmacol. 1983; 32: 3755
   PubMed Web of Science ®Google Scholar
• Ishii K., Maeda K., Kamataki T., Kato R. Mutagenic activation of aflatoxin B, by several forms of purified cytochrome P-450. Mutat. Res. 1986; 174: 85
   PubMed Web of Science ®Google Scholar
• Shimada T., Guengerich F. P. Evidence for cytochrome P-450NF, the nifedipine oxidase. being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 462
   PubMed Web of Science ®Google Scholar
• Safe S. Polychiorinated biphenyls (PCBs): mutagenicity and carcinogemcity. Mutat. Res 1989; 220(31)
   PubMedGoogle Scholar
• Faletto M. B., Koser P. L., Battula N., Townsend G. K., Maccubbin A. E., Geiboin H. V., Gurtoo H. L. Cytochrome P,-450 cDNA encodes aflatoxin B,-4-hydroxylase. J. Biol. Chem. 1988; 263: 12187
   PubMed Web of Science ®Google Scholar
• Yang F., Lin L., Wu D., Yang C., Liang J., Chen W., Wang P., Zhang C., Xue E., Du H., Gao S., Ye Z., Sun C., Nebert D. W. The influence of cigarette smoke on the carcinogenic effect of AFB1 in ducks. Chin. J. Clin. Oncot. 1987; 14: 250
   Google Scholar
• Lin L., Yang F., Ye Z., Xu E., Yang C., Zhang C., Wu D., Elashoff J. D., Nebert D. W. Protective effect of cigarette smoking on the incidence of primary hepatoma in an aflatoxin-endemic region of China, submitted
   Google Scholar
• Shichi H., Gaasterland D. E., Jensen N. M., Nebert D. W. TheAh locus: genetic differences in susceptibility to cataracts caused by acetaminophen. Science 1978; 200: 539
   PubMed Web of Science ®Google Scholar
• Shichi H., Tanaka Y., Jensen N. M., Nebert D. W. Genetic differences in cataracl and other ocular abnormalities induced by paracetamol and naphthalene. Pharmacology 1980; 20: 229
   PubMed Web of Science ®Google Scholar
• Wells P. G., Wilson B., Lubek B. M. In vivo murine studies on the biochemical mechanism of naphthalene cataractogenesis. Toxicol. Appl. Pharmacol. 1989; 99: 466
   PubMed Web of Science ®Google Scholar
• Gaskin F., Clayton R. B. An interstrain difference in cholesterol synthesisin vitro in mice, dependent upon a difference in endogenous NADPH-generating capacity. J. Lipid Res. 1972; 13: 106
   PubMedGoogle Scholar
• Blumer J. L., Mieyal J. J. Genetic expression of microsomal electron transport in mice. Different patterns of dependence of constitutive cytochrome P-450 reductase activity on pyridine nucleotide concentrations, y. Biol. Chem. 1978; 253: 1159
   Google Scholar
• Mattison D. R., Thorgeirsson S. S. Ovarian aryl hydrocarbon hydroxylase activity and primordial oocyte toxicity of polycyclic aromatic hydrocarbons in mice. Cancer Res. 1979; 39: 3471
   PubMed Web of Science ®Google Scholar
• Mattison D. R., Thorgeirsson S. S. Gonadal aryl hydrocarbon hydroxylase in rats and mice. Cancer Res. 1978; 38: 1368
   PubMed Web of Science ®Google Scholar
• Mattison D. R., Thorgeirsson S. S. Smoking and industrial pollution, and their effects on menopause and ovarian cancer. Lancet 1978; i: 187
   Google Scholar
• Jones K. G., Sweeney G. D. Dependence of the prophyrogenic effect of 2,3,7,8-tetrachlorodibenzo[p]dioxin upon inheritance of aryl hydrocarbon hydroxyiase responsiveness. Toxicol. Appl. Pharmacol. 1980; 53: 42
   PubMed Web of Science ®Google Scholar
• Greig J. B., Francis J. E., Kay S. J. E., Lovell D. P., Smith A. G. incomplete correlation of 2,3,7,8-tetrachiorodibenzo-(p)-dioxin hepatotoxicity withAh phenotype in mice. Toxicol. Appl. Pharmacol. 1984; 74: 17
   PubMed Web of Science ®Google Scholar
• Jones K. G., Cole F. M., Sweeney G. D. The role of iron in the toxicity of 2,3,7,8-tetrachlorodibenzo(p)dioxin (TCDD). Toxicol. Appl. Pharmacol. 1981; 61: 74
   PubMed Web of Science ®Google Scholar
• Smith A. G., Francis J. E. Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice. Biochem. J. 1983; 214: 909
   PubMed Web of Science ®Google Scholar
• Hahn M. E., Gasiewicz T. A., Linko P., Goldstein J. A. The role of theAh locus in hexachlorobenzene-induced porphyria. Studies in congenic C57BL/6J mice. Biochem. J. 1988; 254: 245
   PubMedGoogle Scholar
• Jacobs J. M., Sinclair P. R., Bement W. J., Lambrecht R. W., Sinclair J. F., Goldstein J. A. Oxidation of uroporphyrinogenby metnylcholanthrene-induced cytochrome P-450: essential role of cytochrome P-450d. Biochem. J. 1989; 258: 247
   PubMed Web of Science ®Google Scholar
• Kuroki J., Koga N., Yoshimura H. High affinity of 2,3,4,7,8-pentaehlorodibenzofuran to cytochrome P-450 in the hepatic microsomes of rats. Chemosphere 1986; 15: 731
   Google Scholar
• Voorman R., Aust S. D. Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P-450d to the cytochrome and inhibiton of its estradiol 2-hydroxylase activity. Toxicol. Appl. Pharmacol. 1987; 90: 69
   PubMed Web of Science ®Google Scholar
• Poland A., Teitelbaum P., Glover E. The [125I]-2-iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: characterization and identification. Mol. Pharmacol 1989; 36: 113
   PubMed Web of Science ®Google Scholar
• Poland A., Teitelbaum P., Glover E., Kende A. Stimulation ofin vivo hepatic uptake andin vitro hepatic binding of [125I]-2-iodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonists for the Ah receptor. Mol. Pharmacol. 1989; 36: 121
   PubMed Web of Science ®Google Scholar
• Voorman R., Aust S. D. Inducers of cytochrome P-450d: influence on microsomal catalytic activities and differential regulation by enzyme stabilization. Arch. Biochem. Biophys 1988; 262: 76
   PubMed Web of Science ®Google Scholar
• Miller D. M., Aust A. E., Voorman R., Aust S. D. Inhibition of 2-aminofluorene mutagenesis in bacteria by inducers of cytochrome P-450d. Carcinogenesis 1988; 9: 327
   PubMedGoogle Scholar
• Levy R. L., Barrington M. H., Lerner R. A., Griffin G. F., Whitmire C. E. Immunosuppressive effects of 3-methylcholanthrene given intratracheally in various strains of mice. Cancer Res. 1977; 37: 3892
   PubMed Web of Science ®Google Scholar
• Silkworth J. B., Grabstein E. M. Polychiorinated biphenyl immunotoxicity: dependence on isomer planarity and theAh gene complex. Toxicol. Appl. Pharmacol. 1982; 65: 109
   PubMed Web of Science ®Google Scholar
• Lubet R. A., Brunda M. J., Taramelli D., Dansie D., Nebert D. W., Kouri R. E. Induction of immunotoxicity by polycyclic hydrocarbons: Role of theAh locus. Arch. Toxicol. 1984; 56: 18
   PubMed Web of Science ®Google Scholar
• Poland A. P., Glover E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin: segregation of toxicity with theAh locus. Mol. Pharmacol. 1980; 17: 86
   PubMed Web of Science ®Google Scholar
• Vecchi A., Sironi M., Canegrati M. A., Recchia M., Garattini S. Immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in strains of mice with different susceptibility to induction of aryl hydrocarbon hydroxylase. Toxicol. Appl. Pharmacol. 1983; 68: 434
   PubMed Web of Science ®Google Scholar
• Nagarkatti P. S., Sweeney G. D., Gauldie J., Clark D. A. Sensitivity to suppression of cytotoxic T cell generation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on theAh genotype of the murine host. Toxicol. Appl. Pharmacol. 1984; 72: 169
   PubMed Web of Science ®Google Scholar
• Holsapple M. P., McNerney P. J., Barnes D. W., White K. L., Jr. Suppression of humoral anitbody production by exposure to 1,2,3,6,7,8-hexachlorodibenzo-p-dioxin. J. Pharmacol. Exp. Ther. 1984; 231: 518
   PubMed Web of Science ®Google Scholar
• Tucker A. N., Vore S. J., Luster M. L. Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 1986; 29: 372
   PubMed Web of Science ®Google Scholar
• Clark G. C., Blank J. A., Germolec D. R., Luster M. L. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) stimulates protein phosphorylation and tyrosine kinase activity in B lymphocytes. Mol. Pharmacol., in press
   Google Scholar
• Faith R. E., Moore J. A. Impairment of thymus-dependent immune functions by exposure of the developing immune system to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J. Toxicol. Environ. Health 1977; 3: 451
   PubMed Web of Science ®Google Scholar
• Dencker L., Hassoun E., d'Argy R., Aim G. Fetal thymus organ culture as anin vitro model for the toxicity of 2,3,7,8-tetra-chlorodibenzo-p-dioxin and its congeners. Mol. Pharmacol. 1985; 27: 133
   PubMedGoogle Scholar
• Fine J. S., Gasiewicz T. A., Silverstone A. E. Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetra-chlorodibenzo-p-dioxin. Mol. Pharmacol. 1989; 35: 18
   PubMed Web of Science ®Google Scholar
• Canga L., Levi R., Rifkind A. B. Heart as a target organ in 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity: decreased β-adrenergic responsiveness and evidence of increased intraceilular calcium. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 905
   PubMed Web of Science ®Google Scholar
• McConkey D. J., Hartzell P., Duddy S. K., Hakansson H., Orrenius S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca+2-mediated endonuclease activation. Science 1988; 242: 256
   PubMed Web of Science ®Google Scholar
• Benditt E., Benditt J. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. U.S.A. 1973; 70: 1753
   PubMed Web of Science ®Google Scholar
• Paigen B., Holmes P. A., Morrow A., Mitchell D. Effect of 3-methylcholanthrene on atherosclerosis in two congenic strains of mice with different susceptibilities to methylcholanthrene-induced tumors. Cancer Res. 1986; 46: 3321
   PubMed Web of Science ®Google Scholar
• Paigen B., Mitchell D., Reue K., Morrow A., Lusis A. J., LeBoeuf R. C. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 3763
   PubMed Web of Science ®Google Scholar
• Paigen B., Nesbitt M. N., Mitchell D., Albee D., LeBoeuf R. C. Ath-2, a second gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Genetics 1989; 122: 163
   PubMedGoogle Scholar
• Poli A., Franceschini G., Puglisi L., Sirtori C. R. Increased total and high density lipoprotein cholesterol with apoprotein changes resembling streptozotocin diabetes in tetrachlorodibenzodioxin (TCDD) treated rats. Biochem. Pharmacol. 1980; 29: 835
   PubMedGoogle Scholar
• Lesca P., Fernandez N., Roy M. The binding components for 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons. Separation from the rat and mouse hepatic cytosol and characterization of a light density component. J. Biol. Chem. 1987; 262: 4827
   PubMed Web of Science ®Google Scholar
• McClearn G. E., Kakihana R. Selective breeding for ethanol sensitivity in mice. Behav. Genet. 1973; 3: 409
   Web of Science ®Google Scholar
• Heston W. D. W., Erwin V. G. A comparison of the effects of alcohol on mice selectively-bred for differences in ethanol sleep time. Life Sci. 1974; 14: 365
   PubMedGoogle Scholar
• French T. A., Atkinson N., Petersen D. R., Chung L. W. K. Differential induction of hepatic microsomal ethanol and drug metabolism by 3-methylcholanthrene in “LS” and “SS” mice. J. Pharmacol. Exp. Ther. 1979; 209: 404
   PubMedGoogle Scholar
• Bigelow S. W., Collins A. C., Nebert D. W. Selective mouse breeding for short ethanol sleeip time has led to high levels of aromatic hydrocarbon (Ah) receptor. Biochem. Pharmacol., in press
   Google Scholar
• Rifkind A. B., Muschick H. Benoxaprofen suppression of polychlorinated biphenyl toxicity without alteration of mixed-function oxidase function. Nature 1983; 303: 524
   PubMed Web of Science ®Google Scholar
• Nebert D. W. Use of fetal cell culture as an experimental system for predicting drug metabolism in the intact animal. Clin. Pharmacol. Ther. 1973; 14: 693
   PubMedGoogle Scholar
• Smith D. W. Smith's Recognizable Patterns of Human Malformation, 4th ed., K. L. Jones. W. B. Saunders, Philadelphia 1988
   Google Scholar
• Lambert G. H., Jensen N. M., Nebert D. W. Genetically mediated induction of drug-metabolizing enzymes associated with congenital defects in the mouse. Teratology 1977; 16: 147
   PubMedGoogle Scholar
• Shum S., Jensen N. M., Nebert D. W. TheAh locus:in utero toxicity and teratogenesis associated with genetic differences in benzo[a]pyrene metabolism. Teratology 1979; 20: 365
   PubMedGoogle Scholar
• Hoshino K., Hayashi Y., Takehira Y., Kameyama Y. Influences of genetic factors on the teratogenicity of environmental pollutants: teratogenic susceptibility to benzo[a]pyrene andAh locus in mice. Congenital Anomalies 1981; 21: 97
   Google Scholar
• Dencker L., Pratt R. M. Association between the presence of theAh receptor in embryonic murine tissues and sensitivity to TCDD-induced cleft palate. Teratogen. Carcinogen. Mutagen. 1981; 1: 399
   Google Scholar
• Hassoun E., d'Argy R., Dencker L., Lundin L.-G., Borwell P. Teratogenicity of 2,3,7,8-tetrachlorodibenzofuran in BXD recombinant inbred strains. Toxicol. Lett. 1984; 23: 37
   PubMed Web of Science ®Google Scholar
• Birnbaum L. S., Weber H., Harris M. W., Lamb J. C., IV, McKinney J. D. Toxic interaction of specific polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin: increased incidence of cleft palate in mice. Toxicol. Appl. Pharmacol. 1985; 77: 292
   PubMed Web of Science ®Google Scholar
• Legraverend C., Guenthner T. M., Nebert D. W. Importance of the route of administration for genetic differences in benzo[a]pyrene-inducedin utero toxicity and teratogenicity. Teratology 1984; 29: 35
   PubMedGoogle Scholar
• Manchester D., Jacoby E. Decreased placental monooxygenase activities associated with birth defects. Teratology 1984; 30: 31
   PubMedGoogle Scholar
• Cytochrome P-450, R. Sato, T. Omura. Kodansha Press, Tokyo 1978
   Google Scholar
• Galloway S. M., Perry P. E., Meneses J., Nebert D. W., Pedersen R. A. Cultured mouse embryos metabolize benzo[a]pyrene during early gestation: genetic differences detectable by sister chromatid exchange. Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 3524
   PubMed Web of Science ®Google Scholar
• Pedersen R. A., Meneses J., Spindle A., Wu K., Galloway S. M. Cytochrome P-450 metabolic activity in embryonic and extraembryonic tissue lineages of mouse embryos. Proc. Natl. Acad. Sci, U.S.A. 1985; 82: 3311
   PubMed Web of Science ®Google Scholar
• Filler R., Lew K. J. Developmental onset of mixed-function oxidase activity in preimplantation mouse embryos. Proc. Natl. Acad. Sci. U.S.A. 1981; 78: 6991
   PubMed Web of Science ®Google Scholar
• Tuteja N., Gonzalez F. J., Nebert D. W. Developmental and tissue-specific differential regulation of the mouse dioxin-inducible P,-450 genes. Dev. Biol. 1985; 112: 177
   PubMed Web of Science ®Google Scholar
• Kimura S., Donovan J. C., Nebert D. W. Expression of the mouse P,450 gene during differentiation without foreign chemical stimulation. J. Exp. Pathol. 1987; 3: 61
   PubMedGoogle Scholar
• Kumaki K., Jensen N. M., Shire J. G. M., Nebert D. W. Genetic differences in induction of cytosol reduced-NAD(P)H:menadione oxidoreductase and microsomal aryl hydrocarbon hydroxylase in the mouse. J. Biol. Chem. 1977; 252: 157
   PubMed Web of Science ®Google Scholar
• Owens I. S. Genetic regulation of UDP-glucuronosyltransferase induction by polycyclic aromatic compounds in mice. Co-segregation with aryl hydrocarbon (benzo[a]pyrene) hydroxylase induction. J. Biol. Chem. 1977; 252: 2827
   PubMed Web of Science ®Google Scholar
• Felton J. S., Ketley J. N., Jakoby W. B., Aitio A., Bend J. R., Nebert D. W. Hepatic glutathione transferase activity induced by polycyclic aromatic compounds. Lack of correlation with the murineAh locus. Mol. Pharmacol. 1980; 18: 559
   PubMed Web of Science ®Google Scholar
• Telakowski-Hopkins C. A., King R. G., Pickett C. B. Glutathione S-transferase Ya subunit gene: identification of regulatory elements required for basal level and inducible expression. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 1000
   PubMed Web of Science ®Google Scholar
• Daniel V., Sharon R., Bensimon A. Regulatory elements controlling the basal and drug-inducible expression of glutathione S-transferase Ya subunit gene. DNA 1989; 8: 399
   PubMedGoogle Scholar
• Jones D. E., Jr., Brennan M. D., Hempel J., Lindahl R. Cloning and complete nucleotide sequence of a full-length cDNA encoding a catalytically functional tumor-associated aldehyde dehydrogenase. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 1782
   PubMed Web of Science ®Google Scholar
• Ishidate K., Tsuruoka M., Nakazawa Y. Induction of choline kinase by polycyclic hydrocarbons in rat liver. II. Its relation to net phosphatidylcholine biosynthesis. Biochim. Biophys. Acta 1982; 713: 103
   PubMedGoogle Scholar
• Carter C. A., Milhoulland R. J., Shea W., Ip M. M. Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-di-methylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res. 1983; 43: 3559
   PubMed Web of Science ®Google Scholar
• Levine L., Ohuchi K. Stimulation by carcinogens and promoters of prostaglandin production by dog kidney (MDCK) cells in culture. Cancer Res. 1978; 38: 4142
   PubMedGoogle Scholar
• Bresnick E., Bailey G., Bonney R. J., Wightman P. Phos pholipase activity in skin after application of phorbol esters and 3-methylcholanthrene. Carcinogenesis 1981; 2: 1119
   PubMedGoogle Scholar
• Gupta B. N., McConnell E. E., Harris M. W., Moore J. A. Polybrominated biphenyl toxicosis in the rat and mouse. Toxicol. Appl. Pharmacol. 1981; 57: 99
   PubMed Web of Science ®Google Scholar
• Bombick D. W., Madhukar B. V., Brewster D. W., Matsumura F. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes increases in protein kinases, particularly protein kinase C, in the hepatic plasma membrane of the rat and guinea pig. Biochem. Biophys. Res. Commun. 1985; 127: 296
   PubMed Web of Science ®Google Scholar
• Kramer C. M., Johnson K. W., Dooley R. K., Holsapple M. P. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances antibody production and protein kinase activity in murine B cells. Biochem. Biophys. Res. Commun. 1987; 145: 25
   PubMed Web of Science ®Google Scholar
• Wong D. T. W., Hartigan J. A., Biswas D. K. Mechanism of induction of human chorionic gonadotropin in lung tumor cells in culture. Increase levels of α-human chorionic gonadotropin-specific mRNA sequences and benzo(a)pyrene-induced hypomethylation. J. Biol. Chem. 1984; 259: 10738
   PubMedGoogle Scholar
• Bombick D. W., Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes elevation of the levels of the protein tyrosine kinase pp60c-src. J. Biochem. Toxicol. 1987; 2: 141
   PubMedGoogle Scholar
• Nagata K., Matsunaga T., Gillette J., Gelboin H. V., Gonzalez F. J. Rat testosterone 7α-hydroxylase isolation, sequence and expression of cDNA and its developmental regulation and induction by 3-methylcholanthrene. J. Biol. Chem. 1987; 262: 2787
   PubMed Web of Science ®Google Scholar
• Korza G., Ozois J. Complete covalent structure of 60-kDa esterase isolated from 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced rabbit liver microsomes. J. Biol Chem. 1988; 263: 3486
   PubMed Web of Science ®Google Scholar
• Bombick D. W., Jankun J., Tullis K., Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increases in expression ofc-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 4128
   PubMed Web of Science ®Google Scholar
• Pohjanvirta R., Juvonen R., Karenlampi S., Raunio H., Tuomisto J. Hepatic Ah-receptor levels and the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on hepatic microsomal monoox-ygenase activities in a TCDD-susceptible and -resistant rat strain. Toxicol. Appl. Pharmacol. 1988; 92: 131
   PubMed Web of Science ®Google Scholar
• Hong L. H., McKinney J. D., Luster M. I. Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated myelotoxicity by thyroid hormones. Biochem. Pharmacol. 1987; 36: 1361
   PubMed Web of Science ®Google Scholar
• Rozman K., Rozman T., Greim H. Effect of thyroidectomy and thyroxmeon 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced toxicity. Toxicol. Appl. Pharmacol. 1984; 72: 372
   PubMed Web of Science ®Google Scholar
• McKinney J. D., Fawkes J., Jordan S., Chae K., Oatley S., Coteman R. E., Briner W. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) as a potent and persistent thyroxine agonist: a mechanistic model for toxicity based on molecular reactivity. Environ. Health Perspect 1985; 61: 41
   PubMedGoogle Scholar
• Nebert D. W. Genes encoding drug-metabolizing enzymes: possible role in human disease. Phenotypic Variation in Populations, A. D. Wood-Head, M. A. Bender, R. C. Leonard. Plenum Press, New York 1988; 45
   Google Scholar